Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Completed 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Head and Neck Neoplasms 41Squamous Cell Carcinoma of Head and Neck 37Prostatic Neoplasms 16Nasopharyngeal Carcinoma 12Carcinoma, Non-Small-Cell Lung 12Glioblastoma 11Uterine Cervical Neoplasms 10Gliosarcoma 10Brain Neoplasms 10Neoplasm Metastasis 9Carcinoma, Squamous Cell 8Breast Neoplasms 8Rectal Neoplasms 7Pancreatic Neoplasms 7Glioma 7Carcinoma 7Tongue Neoplasms 6Radiation Injuries 6Oropharyngeal Neoplasms 6Neoplasms 6Lung Neoplasms 6Astrocytoma 6Sarcoma 5Nasopharyngeal Neoplasms 5Papillomavirus Infections 4Endometrial Neoplasms 4Salivary Gland Neoplasms 3Oligodendroglioma 3Mouth Neoplasms 3Laryngeal Neoplasms 3

Interventions

tocotrienol, delta 1dehydroftorafur 1X-Rays 1Specimen Handling 1Radiotherapy, Intensity-Modulated 1Radiotherapy, Conformal 1Phantoms, Imaging 1Paclitaxel 1Magnetic Resonance Spectroscopy 1Gemcitabine 1Fluorouracil 1Ethanol 1Erlotinib Hydrochloride 1Drug Therapy 1Capecitabine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Pancreatic Intraductal Neoplasms × Radiotherapy, Intensity-Modulated × Clear all
NCT01013649 2026-02-23

Gemcitabine Hydrochloride With or Without Erlotinib Hydrochloride Followed by the Same Chemotherapy Regimen With or Without Radiation Therapy and Capecitabine or Fluorouracil in Treating Patients With Pancreatic Cancer That Has Been Removed by Surgery

National Cancer Institute (NCI)

Phase 3 Completed
546 enrolled 29 charts
Gastrointestinal

Pancreatic Intraductal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡